Protective effect of Pentadecapeptide BPC 157 against experimental colitis involves neuropeptides neurokinin1 receptor/substance P system activation: role for mast cells degranulation inhibition via mitogenactivated protein kinases pathways modulation Cell Signal 27(5): 9961007 Kiefer JW Jr., Lee CLF
The danger zone is real: BPC-157 reduces pain and inflammation quickly, often within weeks 1 to 4
Certificate of Analysis available upon request
Retatrutide has not been approved for human use in the UK, and reconstitution and administration outside of a formal, ethics-approved clinical trial is not sanctioned by any UK regulatory body
Concentrations of GHK-Cu in the body decline significantly with age, from approximately 200 ng/mL in young adults to under 80 ng/mL by age 60, making topical replenishment meaningful
Disguised Alpha personally vetted the laboratory partners we work with before building those relationships